frozach submitted
Proteus Biomedical has received CE Mark approval from the European Union to bring to market the firm’s Raisin ingestible drug sensors and monitoring system. When a patient swallows tablets that have individually tagged beacons on them, a sensor can automatically record the precise time and basic vital signs of the patient at that time. The system allows physicians to get a better picture of how a patient responds to a given medication.
Read more here.
The intelligent pill caps, which use flashing lights and audio reminders, as well as phone calls and SMS, to remind forgetful patients that it’s down-the-hatch time, retail between $10 and $15 a month through a Vitality connectivity service plan.
Read more here.